Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

To main content To sitemap To news Check availability details

Travel grant 2026 Nordic Summit Japan Bio Korea 22-29 April

Reference number
Coordinator Buzzard Pharmaceuticals AB
Funding from Vinnova SEK 25 000
Project duration April 2026 - April 2026
Status Ongoing
Call Travel grant Vinnova 2026

Purpose and goal

Buzzard Pharmaceuticals is participating in Nordic Health Summit Japan&South Korea to discuss our clinical project in oncology and rare diseases isunakinra with potential collaboration partners and research groups.

Expected effects and result

We expect to establish contacts with companies focusing on oncology and rare diseases in Japan and Korea for future collaborations.

Planned approach and implementation

Participation in Nordic Health Summit in Japan and South Korea and participation in the Bio Korea conference.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 27 March 2026

Reference number 2026-00422